Both are highly purified botulinum toxin type A, but molecular structure and diffusion differ, so each has suitable uses.

Botox and Xeomin share the same core principle: highly purified botulinum toxin type A is used to precisely block acetylcholine release between nerve endings and muscle, temporarily relaxing overactive muscle and achieving wrinkle reduction, facial slimming and other effects.
| Comparison | Botox | Xeomin |
|---|---|---|
| Origin | Allergan, USA | Merz, Germany |
| Molecular structure | Core neurotoxin plus complexing proteins (about 900 kDa) | Pure botulinum toxin with zero complexing protein (about 150 kDa) |
| Diffusion | Wider spread | More concentrated spread, favourable for precise fine-tuning |
Both products are recognised by the FDA and the Hong Kong Department of Health. Common reactions are brief mild redness, swelling or bruising, which settle within a few days. Botox contains complexing proteins, so long-term, frequent, high-dose injection carries a higher chance of forming neutralizing antibodies; Xeomin has the complexing proteins removed, lowering the risk of an immune response. A “frozen face” usually comes from excessive dose or inaccurate injection depth, not from the brand itself, and must be performed by a registered doctor.